MedWatch

A part of Watch Media

Component shortages impact WSA

A current trend in the hearing aid industry has been a lack of components for their devices, and WS Audiology, which is dedicated to securing its supply chain, has also seen a smaller effect in recent reporting.

Last October, GN Hearing had to downgrade lower its expectations due to component shortages. WSA, too, has been impacted | Photo: WS Audiology / PR
by CHRISTIAN BUNDGAARD, translated by daniel pedersen

Component shortages and high shipping rates are almost the new normal for companies that produce anything electronic.

A few of WS Audiology’s products have been impacted by component scarcity, CEO of WSA Eric Bernard tells MedWatch in connection with the first quarter report of financial year 2021/2022 on Thursday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Foto: Russell Cheyne/Reuters/Ritzau Scanpix

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

  1. GN purchase story is very speculative, says analyst
  2. Novo Nordisk invests additional millions of dollars in new manufacturing facilities
  3. CHMP to remove 100 generic medicines from market
  4. Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
  5. Rumored purchase of GN Group could mean divestment of hearing aid division, says media
  6. EMA publishes new plan to support antibiotic development
  7. New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
  8. Dexcom is in talks to acquire device firm Insulet
  9. Bavarian Nordic ramps up monkeypox vaccine production
  10. Carb-X secures USD 370m in fight against antibiotic resistance
  11. Former Ambu CEO's equity investments end in USD 2m losses
  12. Jesper Høiland retires as chief commercial officer of Ascendis Pharma
  13. Monkeypox vaccine attracts interest for Bavarian as virus spreads
  14. Almirall announces Danish launch of MC2 Therapeutics-developed psoriasis cream
  15. ALK finds replacement for long-time North America lead

See all

Job

See all jobs

See all jobs